| A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies (NCT00109707) | Novartis Pharmaceuticals | 2005-04-01 |
| To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250mg/5 ml Oral Suspension Fasting Conditions (NCT00882570) | Sandoz | 2005-04-01 |
| Youth Empowerment Solutions for Peaceful Communities (NCT00164593) | Centers for Disease Control and Prevention | 2005-04-01 |
| Safety and Immunogenicity Testing of Influenza Vaccine in Healthy Children 2 Months and 6 Months of Age (NCT00858468) | Sanofi Pasteur, a Sanofi Company | 2005-04-01 |
| Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer. (NCT00209729) | Hokkaido Gastrointestinal Cancer Study Group | 2005-04-01 |
| Methotrexate, Trimetrexate Glucuronate, and Leucovorin in Treating Patients With Refractory or Recurrent Osteosarcoma (NCT00119301) | Memorial Sloan Kettering Cancer Center | 2005-04-01 |
| A Notch Signalling Pathway Inhibitor for Patients With Advanced Breast Cancer (0752-014) (NCT00106145) | Merck Sharp & Dohme LLC | 2005-04-01 |
| Study of the Blood Levels and Effects of ATL-962 on Fat Excretion in Obese Subjects (NCT00148382) | Alizyme | 2005-04-01 |
| Radiation Dose Escalation Study for Advanced Liver Cancer (NCT00848094) | Fudan University | 2005-04-01 |
| Continuous Positive Airway Pressure Ventilation After Acute Ischemic Stroke (NCT00151177) | University Hospital Muenster | 2005-04-01 |
| CBT With Disulfiram and Contingency Management (NCT00350870) | Yale University | 2005-04-01 |
| Food Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg (NCT00647881) | Mylan Pharmaceuticals Inc | 2005-04-01 |
| Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer (NCT00118300) | Case Comprehensive Cancer Center | 2005-04-01 |
| A Relative Bioavailability Study of Propranolol Hydrochloride 160 mg Tablets Under Fasting Conditions (NCT00865215) | Actavis Inc. | 2005-04-01 |
| A Study To Compare The Effects Of The Infusion Of A Sepsis Drug Between Healthy Adults And Adults With Damaged Livers (NCT00158769) | GlaxoSmithKline | 2005-03-31 |
| Vaccine to Prevent West Nile Virus Disease (NCT00106769) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-22 |
| Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction (NCT00114452) | Mesoblast, Inc. | 2005-03-22 |
| Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain (NCT00482378) | Mayo Clinic | 2005-03-21 |
| A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid Tumors (NCT00742131) | GlaxoSmithKline | 2005-03-17 |
| Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast Cancer (NCT00140738) | GlaxoSmithKline | 2005-03-10 |
| Improving the Efficacy of Experimental Malaria Vaccine AMA1-C1/Alhydrogel® (Registered Trademark) (NCT00340574) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-08 |
| Effect of Nitrite on Exercise Physiology and Metabolism (NCT00105222) | National Heart, Lung, and Blood Institute (NHLBI) | 2005-03-08 |
| PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria (NCT00295581) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-07 |
| Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma (NCT00673010) | Memorial Sloan Kettering Cancer Center | 2005-03-07 |
| Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer (NCT00582140) | University of Wisconsin, Madison | 2005-03-01 |
| Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer (NCT00217516) | Roswell Park Cancer Institute | 2005-03-01 |
| Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer (NCT00084721) | Roswell Park Cancer Institute | 2005-03-01 |
| Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors (NCT00660426) | Washington University School of Medicine | 2005-03-01 |
| Effect of BIA 2-093 on the Pharmacokinetics of a Combined Oral Contraceptive. (NCT02281448) | Bial - Portela C S.A. | 2005-03-01 |
| Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes (NCT00104962) | National Cancer Institute (NCI) | 2005-03-01 |
| Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic Cancer (NCT00281996) | Northwestern University | 2005-03-01 |
| Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer (NCT01147991) | Cancer Research UK | 2005-03-01 |
| Pravastatin 80 mg Tablets Dosed in Healthy Subjects Under Non-Fasting Conditions (NCT00829309) | Teva Pharmaceuticals USA | 2005-03-01 |
| Aspirin Prophylaxis in Sickle Cell Disease (NCT00178464) | University of Rochester | 2005-03-01 |
| Using Dexamethasone After Uvulopalatopharyngoplasty (NCT00584168) | University of Oklahoma | 2005-03-01 |
| Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) Study (NCT00281073) | EP MedSystems | 2005-03-01 |
| Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1 (NCT00265278) | National Institute on Drug Abuse (NIDA) | 2005-03-01 |
| Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke (NCT00507806) | ImaRx Therapeutics | 2005-03-01 |
| Lorazepam for the Treatment of Status Epilepticus in Children (NCT00114569) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2005-03-01 |
| 17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT00121264) | National Cancer Institute (NCI) | 2005-03-01 |
| An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer (NCT00214838) | Callisto Pharmaceuticals | 2005-03-01 |
| Evaluation of the Preventing AIDS Through Live Movement and Sound (PALMS) Intervention for Minority Adolescents (NCT00137644) | Centers for Disease Control and Prevention | 2005-03-01 |
| A Modified Phase I Study of NGR-hTNF in Advanced Solid Tumors (NCT00419328) | AGC Biologics S.p.A. | 2005-03-01 |
| T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) (NCT00242515) | National University Hospital, Singapore | 2005-03-01 |
| Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT00112476) | National Cancer Institute (NCI) | 2005-03-01 |
| Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia (NCT00109356) | Novacea | 2005-03-01 |
| An Open-label, Single-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093 (NCT02281422) | Bial - Portela C S.A. | 2005-03-01 |
| Bioavailability Study of Oxandrolone Tablets Under Fasting Conditions (NCT00652886) | Par Pharmaceutical, Inc. | 2005-03-01 |
| Cefdinir for Oral Suspension 250 mg/5mL, Non-fasting (NCT00835549) | Teva Pharmaceuticals USA | 2005-03-01 |
| Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide (NCT00250211) | AHS Cancer Control Alberta | 2005-03-01 |
| Hexvix Photodynamic Therapy in Patients With Bladder Cancer (NCT01303991) | Photocure | 2005-03-01 |
| Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia (NCT00370084) | Forest Laboratories | 2005-03-01 |
| PolyArginine Treated vEiN grafTs (PATENT) (NCT00264706) | Lumen Therapeutics | 2005-03-01 |
| Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia (NCT00258271) | University of Rochester | 2005-03-01 |
| Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT00112853) | National Cancer Institute (NCI) | 2005-03-01 |
| Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults (NCT00133471) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-01 |
| Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment (NCT00105417) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-01 |
| Codeine in Sickle Cell Disease (NCT00174538) | PriCara, Unit of Ortho-McNeil, Inc. | 2005-03-01 |
| A Study To Find The Best Doses Of SU011248 And Gemcitabine When Given Together To Patients With Advanced Solid Tumors (NCT00615446) | Pfizer | 2005-03-01 |
| CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies (NCT01653158) | Pfizer | 2005-03-01 |
| Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer (NCT00118261) | Case Comprehensive Cancer Center | 2005-03-01 |
| Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma (NCT00124657) | St. Jude Children's Research Hospital | 2005-03-01 |
| Prophylactic Transfer of Leukemia-reactive T Cells After Allogeneic Transplantation (NCT00460629) | University Hospital Carl Gustav Carus | 2005-03-01 |
| Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors (NCT00387322) | University of California, Davis | 2005-03-01 |
| Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma (NCT00093704) | Jonsson Comprehensive Cancer Center | 2005-03-01 |
| Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies (NCT00990717) | University Health Network, Toronto | 2005-03-01 |
| Can Aprotinin Reduce Pancreatitis After Scoliosis Surgery (NCT00357851) | Nemours Children's Clinic | 2005-03-01 |
| Evaluation of Three Continuation Therapies After ECT Concerning Efficacy and Cognition in Severly Depressed Patients (NCT00437385) | Charite University, Berlin, Germany | 2005-03-01 |
| Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance (NCT00130286) | Weill Medical College of Cornell University | 2005-03-01 |
| A Methodological Open Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarization and QT Interval At Fixed Heart Rate Under Autonomic Blockade (NCT00174512) | Pfizer | 2005-03-01 |
| A Controlled Breathing Course for Social & Emotional Health for Vietnam Veterans With Chronic PTSD-RCT (NCT00256477) | The University of Queensland | 2005-03-01 |
| Iron-Chelating Therapy and Friedreich Ataxia (NCT00224640) | Assistance Publique - Hôpitaux de Paris | 2005-03-01 |
| Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes (NCT00223067) | University Hospital Schleswig-Holstein | 2005-03-01 |
| Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas (NCT00101270) | National Cancer Institute (NCI) | 2005-03-01 |
| Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis (NCT00125333) | Anesiva, Inc. | 2005-03-01 |
| Rituximab in the Treatment of Patients With Bullous Pemphigoid (NCT00286325) | Duke University | 2005-03-01 |
| Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer (NCT00107094) | Celgene Corporation | 2005-03-01 |
| Pharmacokinetics/Pharmacodynamics (PK/PD) of Cangrelor (NCT00102674) | The Medicines Company | 2005-03-01 |
| Study of CGC-11047 (PG-11047) in Subjects With Advanced Refractory Solid Tumors (NCT00705653) | Progen Pharmaceuticals | 2005-03-01 |
| A Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P) (NCT00977600) | Amgen | 2005-03-01 |
| Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors (NCT00394446) | Myrexis Inc. | 2005-03-01 |
| A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer (NCT00162318) | Eli Lilly and Company | 2005-03-01 |
| Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides. (NCT00226993) | Stanford University | 2005-03-01 |
| A/H5N1in Adult - Aventis (NCT00115986) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-01 |
| Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram (NCT00613470) | Mayo Clinic | 2005-03-01 |
| Intervening Early With Neglected Children (NCT02093052) | University of Delaware | 2005-03-01 |
| Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors (NCT00276575) | Herbert Hurwitz, MD | 2005-03-01 |
| Pharmacokinetic Interaction Between TRUVADA™ and BILR 355 BS Plus Ritonavir in Healthy Volunteers (NCT02253901) | Boehringer Ingelheim | 2005-03-01 |
| Comparing Over-the-counter Dry Mouth Remedies After Radiation (NCT00595933) | University of Oklahoma | 2005-03-01 |
| Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma (NCT00155272) | National Taiwan University Hospital | 2005-03-01 |
| MLN518 in Combination With Standard Induction Chemo. for Treatment of Patients With Newly Diagnosed Acute Myelogenous Leukemia (NCT00274248) | Millennium Pharmaceuticals, Inc. | 2005-03-01 |
| Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients. (NCT00695851) | Memorial Sloan Kettering Cancer Center | 2005-03-01 |
| Dendritic Cell Vaccination for Patients With Acute Myeloid Leukemia in Remission (NCT00834002) | University Hospital, Antwerp | 2005-03-01 |
| Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS in Healthy Male Volunteers (NCT02214901) | Boehringer Ingelheim | 2005-03-01 |
| Comparative Bioavailability Study of Two Prototypes of Trazodone Controlled-release Products and Two Marketed Reference Products in Healthy Volunteers (NCT01121913) | Labopharm Inc. | 2005-03-01 |
| Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women (NCT01477632) | Novo Nordisk A/S | 2005-03-01 |
| Ivermectin Solution Bioequivalence Study - Fasted (NCT00921154) | Johnson & Johnson Consumer and Personal Products Worldwide | 2005-03-01 |
| Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA (NCT00148928) | GlaxoSmithKline | 2005-03-01 |
| Study of Atiprimod Treatment for Patients With Advanced Cancer (NCT00430014) | M.D. Anderson Cancer Center | 2005-03-01 |
| Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma (NCT00118274) | Craig L Slingluff, Jr | 2005-03-01 |